Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

Effect of Permissive Dehydration on Induction and Decay of Heat Acclimation, and Temperate Exercise Performance.

Neal RA, Massey HC, Tipton MJ, Young JS, Corbett J.

Front Physiol. 2016 Nov 23;7:564. eCollection 2016.

2.

On the use of Bayesian decision theory for issuing natural hazard warnings.

Economou T, Stephenson DB, Rougier JC, Neal RA, Mylne KR.

Proc Math Phys Eng Sci. 2016 Oct;472(2194):20160295.

3.

Effect of short-term heat acclimation with permissive dehydration on thermoregulation and temperate exercise performance.

Neal RA, Corbett J, Massey HC, Tipton MJ.

Scand J Med Sci Sports. 2016 Aug;26(8):875-84. doi: 10.1111/sms.12526. Epub 2015 Jul 29.

PMID:
26220213
4.

Spatiotemporal oxygen sensing using dual emissive boron dye-polylactide nanofibers.

Bowers DT, Tanes ML, Das A, Lin Y, Keane NA, Neal RA, Ogle ME, Brayman KL, Fraser CL, Botchwey EA.

ACS Nano. 2014 Dec 23;8(12):12080-91. doi: 10.1021/nn504332j. Epub 2014 Nov 26.

5.

Laminin- and basement membrane-polycaprolactone blend nanofibers as a scaffold for regenerative medicine.

Neal RA, Lenz SM, Wang T, Abebayehu D, Brooks BP, Ogle RC, Botchwey EA.

Nanomater Environ. 2014 Sep;2(1):1-12. Epub 2014 Sep 1.

6.

Adaptation to heat and exercise performance under cooler conditions: a new hot topic.

Corbett J, Neal RA, Lunt HC, Tipton MJ.

Sports Med. 2014 Oct;44(10):1323-31. doi: 10.1007/s40279-014-0212-8. Review.

PMID:
24943043
7.

Three-dimensional elastomeric scaffolds designed with cardiac-mimetic structural and mechanical features.

Neal RA, Jean A, Park H, Wu PB, Hsiao J, Engelmayr GC Jr, Langer R, Freed LE.

Tissue Eng Part A. 2013 Mar;19(5-6):793-807. doi: 10.1089/ten.tea.2012.0330. Epub 2012 Nov 28.

8.

Alignment and composition of laminin-polycaprolactone nanofiber blends enhance peripheral nerve regeneration.

Neal RA, Tholpady SS, Foley PL, Swami N, Ogle RC, Botchwey EA.

J Biomed Mater Res A. 2012 Feb;100(2):406-23. doi: 10.1002/jbm.a.33204. Epub 2011 Nov 21.

9.

The use of surface modified poly(glycerol-co-sebacic acid) in retinal transplantation.

Pritchard CD, Arnér KM, Neal RA, Neeley WL, Bojo P, Bachelder E, Holz J, Watson N, Botchwey EA, Langer RS, Ghosh FK.

Biomaterials. 2010 Mar;31(8):2153-62. doi: 10.1016/j.biomaterials.2009.11.074. Epub 2009 Dec 4.

10.

Phthalimide neovascular factor 1 (PNF1) modulates MT1-MMP activity in human microvascular endothelial cells.

Wieghaus KA, Gianchandani EP, Neal RA, Paige MA, Brown ML, Papin JA, Botchwey EA.

Biotechnol Bioeng. 2009 Jul 1;103(4):796-807. doi: 10.1002/bit.22310.

11.

Nanomedicine: Addressing Cardiovascular Disease and Cardiovascular Tissue Regeneration.

Neal RA, Oredein-McCoy O, Botchwey EA.

Curr Bioact Compd. 2009;5(3):206-214. doi: 10.2174/157340709789054722.

12.

Laminin nanofiber meshes that mimic morphological properties and bioactivity of basement membranes.

Neal RA, McClugage SG, Link MC, Sefcik LS, Ogle RC, Botchwey EA.

Tissue Eng Part C Methods. 2009 Mar;15(1):11-21. doi: 10.1089/ten.tec.2007.0366.

13.

Collagen nanofibres are a biomimetic substrate for the serum-free osteogenic differentiation of human adipose stem cells.

Sefcik LS, Neal RA, Kaszuba SN, Parker AM, Katz AJ, Ogle RC, Botchwey EA.

J Tissue Eng Regen Med. 2008 Jun;2(4):210-20. doi: 10.1002/term.85.

14.

The trouble with TEFs.

Starr TB, Greenlee WF, Neal RA, Poland A, Sutter TR.

Environ Health Perspect. 1999 Oct;107(10):A492-3.

15.

A career in toxicology.

Neal RA.

Annu Rev Pharmacol Toxicol. 1996;36:34-46. No abstract available.

PMID:
8725381
16.

The sensitivity of Leishmania species to aminosidine.

Neal RA, Allen S, McCoy N, Olliaro P, Croft SL.

J Antimicrob Chemother. 1995 May;35(5):577-84.

PMID:
7592170
17.

The discipline of toxicology.

Neal RA, Doull J.

Fundam Appl Toxicol. 1995 Feb;24(2):151-3. No abstract available.

PMID:
7737426
18.

EPA dioxin reassessment.

Bradfield CA, Gallo MA, Gasiewicz TA, Greenberg RS, Greenlee WF, Margolick J, Mattison DR, Munson P, Neal RA, Okey AB, et al.

Science. 1994 Dec 9;266(5191):1628-9. No abstract available.

PMID:
7992038
19.

Aminosidine ointments for the treatment of experimental cutaneous leishmaniasis.

Neal RA, Murphy AG, Olliaro P, Croft SL.

Trans R Soc Trop Med Hyg. 1994 Mar-Apr;88(2):223-5.

PMID:
8036682
20.

Antileishmanial activity of the ether phospholipid ilmofosine.

Croft SL, Neal RA, Thornton EA, Herrmann DB.

Trans R Soc Trop Med Hyg. 1993 Mar-Apr;87(2):217-9.

PMID:
8337733
21.

The activity of platinum, iridium and rhodium drug complexes against Leishmania donovani.

Croft SL, Neal RA, Craciunescu DG, Certad-Fombona G.

Trop Med Parasitol. 1992 Mar;43(1):24-8.

PMID:
1598504
22.

Immune-dependence of chemotherapy of experimental visceral leishmaniasis.

Iwobi MU, Doenhoff MJ, Neal RA.

Trans R Soc Trop Med Hyg. 1991 Jan-Feb;85(1):56-7. No abstract available.

PMID:
1648805
23.

A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment.

el-Safi SH, Murphy AG, Bryceson AD, Neal RA.

Trans R Soc Trop Med Hyg. 1990 Sep-Oct;84(5):690-1. No abstract available.

PMID:
2278070
24.

Leishmania infecting man and wild animals in Saudi Arabia. 8. The influence of prior infection with Leishmania arabica on challenge with L. major in man.

Peters W, Bryceson A, Evans DA, Neal RA, Kaye P, Blackwell J, Killick-Kendrick R, Liew FY.

Trans R Soc Trop Med Hyg. 1990 Sep-Oct;84(5):681-9.

PMID:
2126153
25.
26.

Antileishmanial effects of clofazimine and other antimycobacterial agents.

Evans AT, Croft SL, Peters W, Neal RA.

Ann Trop Med Parasitol. 1989 Oct;83(5):447-54.

PMID:
2619361
27.

Quantitative determination of Leishmania amastigotes--an addendum.

Cenini P, Reeves AM, Neal RA.

Trans R Soc Trop Med Hyg. 1989 Jul-Aug;83(4):575. No abstract available.

PMID:
2617618
28.

Zymodeme analysis of laboratory strains of Trypanosoma cruzi in relation to drug susceptibility.

Van Bueren J, Hodson S, Miles MA, Neal RA.

Trans R Soc Trop Med Hyg. 1989 Mar-Apr;83(2):207. No abstract available.

PMID:
2692228
29.

Two new techniques for quantitative determination of Leishmania amastigotes.

Cenini P, Reeve AM, Neal RA.

Trans R Soc Trop Med Hyg. 1989 Mar-Apr;83(2):194-5. No abstract available.

PMID:
2609370
30.

Reversal of drug resistance in Trypanosoma cruzi and Leishmania donovani by verapamil.

Neal RA, van Bueren J, McCoy NG, Iwobi M.

Trans R Soc Trop Med Hyg. 1989 Mar-Apr;83(2):197-8.

PMID:
2558433
31.

Hydrazide antidepressants possess novel antileishmanial activity in vitro and in vivo.

Evans AT, Croft SL, Peters W, Neal RA.

Ann Trop Med Parasitol. 1989 Feb;83(1):19-24.

PMID:
2596901
32.
33.

Selective inhibition of Leishmania dihydrofolate reductase and Leishmania growth by 5-benzyl-2,4-diaminopyrimidines.

Sirawaraporn W, Sertsrivanich R, Booth RG, Hansch C, Neal RA, Santi DV.

Mol Biochem Parasitol. 1988 Oct;31(1):79-85.

PMID:
3185614
34.
35.
36.

Comparative studies of drug susceptibility of five strains of Trypanosoma cruzi in vivo and in vitro.

Neal RA, van Bueren J.

Trans R Soc Trop Med Hyg. 1988;82(5):709-14.

PMID:
3075357
37.

The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani.

Croft SL, Neal RA, Pendergast W, Chan JH.

Biochem Pharmacol. 1987 Aug 15;36(16):2633-6.

PMID:
3606662
38.

Oxidative metabolism of carbon disulfide by isolated rat hepatocytes and microsomes.

Chengelis CP, Neal RA.

Biochem Pharmacol. 1987 Feb 1;36(3):363-8.

PMID:
3814176
39.

Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria.

Belazzoug S, Neal RA.

Trans R Soc Trop Med Hyg. 1986;80(4):670-1. No abstract available.

PMID:
3544363
40.

The activity of plumbagin and other electron carriers against Leishmania donovani and Leishmania mexicana amazonensis.

Croft SL, Evans AT, Neal RA.

Ann Trop Med Parasitol. 1985 Dec;79(6):651-3. No abstract available.

PMID:
3834847
42.

Problems arising after a new compound has shown proven activity in the laboratory.

Neal RA.

Parasitology. 1985 Apr;90 ( Pt 4):717-21. No abstract available.

PMID:
4011324
44.

The effect of allopurinol ribonucleoside and formycin B on Trypanosoma cruzi infections in mice.

Croft SL, Neal RA.

Trans R Soc Trop Med Hyg. 1985;79(4):517-8.

PMID:
3936241
45.

Immunization of marmosets with Trypanosoma cruzi cell surface glycoprotein (GP90).

Scott MT, Neal RA, Woods NC.

Trans R Soc Trop Med Hyg. 1985;79(4):451-4.

PMID:
3936239
46.

The vaccine potential of cell surface glycoproteins from Trypanosoma cruzi.

Scott MT, Neal RA.

Philos Trans R Soc Lond B Biol Sci. 1984 Nov 13;307(1131):63-72.

PMID:
6151689
47.
48.
49.

Distribution, excretion, and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J, DBA/2J, and B6D2F1/J mice.

Gasiewicz TA, Geiger LE, Rucci G, Neal RA.

Drug Metab Dispos. 1983 Sep-Oct;11(5):397-403.

PMID:
6138222

Supplemental Content

Support Center